Stocktoria
Akzo Nobel N.V. AKZA.AS
Akzo Nobel N.V. (AKZA.AS) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the grey zone. It pays a dividend yielding 3.76% (safety: stretched). FY2025 revenue was $10.2B at a 6.3% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Basic Materials · percentile among 19 companies
Percentile vs other Basic Materials companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.133 |
| Retained earnings / assets | 0.04 |
| EBIT / assets | 0.083 |
| Equity / liabilities | 0.51 |
FAQ
Is AKZA.AS financially healthy?
Akzo Nobel N.V.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does AKZA.AS pay a dividend, and is it safe?
Yes. Akzo Nobel N.V. pays a dividend yielding about 3.76% with a 60.2% payout ratio, rated “stretched” for safety.
How profitable is AKZA.AS?
In FY2025, Akzo Nobel N.V. had a net margin of 6.3% and a return on equity of 13.6%.
Source: company filings via Yahoo Finance · NL · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.